Oruka Therapeutics, Inc.

SecurityORKA / Oruka Therapeutics, Inc.
InstitutionWoodline Partners LP
Latest Disclosed Ownership285,247 shares
Latest Disclosed Value $ 27,146,957
Woodline Partners LP ownership in ORKA / Oruka Therapeutics, Inc.

IMPORTANT: This company has reported a 12 to 1 reverse split as of 2024-09-03. The ownership data on this page IS NOT adjusted for this split. It is incumbent upon the reader to determine if this split affects this data and adjust the figures appropriately. Our engineering team is working on a solution to provide split-adjusted figures in the future.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-08-14 2026-06-30 13F ORUKA THERAPEUTICS COM 687604108 285,247 -289,635 -50.38 27,147 -3.73 0.0839
2026-05-15 2026-03-31 13F/A-1 ORUKA THERAPEUTICS COM 687604108 574,882 329 0.06 28,198 61.92 0.1066
2026-05-15 2026-03-31 13F ORUKA THERAPEUTICS COM 687604108 574,882 329 28,198 0.1066
2026-02-17 2025-12-31 13F ORUKA THERAPEUTICS COM 687604108 574,553 223 0.04 17,415 57.68 0.0675
2025-11-14 2025-09-30 13F ORUKA THERAPEUTICS COM 687604108 574,330 183,426 46.92 11,044 152.03 0.0520
2025-08-14 2025-06-30 13F ORUKA THERAPEUTICS COM 687604108 390,904 100 0.03 4,382 9.30 0.0231
2025-05-15 2025-03-31 13F ORUKA THERAPEUTICS COM 687604108 390,804 -165 -0.04 4,010 -47.11 0.0261
2025-02-14 2024-12-31 13F ORUKA THERAPEUTICS COM 687604108 390,969 174 0.04 7,581 -20.86 0.0512
2024-11-14 2024-09-30 13F ORUKA THERAPEUTICS COM 687604108 390,795 390,795 9,578 0.0807
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.